Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Testing effectiveness (Phase 2)Study completedNCT00586911
What this trial is testing

Betaine in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Mayo Clinic 26
Early research (Phase 1)Study completedNCT04561245
What this trial is testing

ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability

Who this might be right for
ObesityNonalcoholic Steatohepatitis
Altimmune, Inc. 100
Not applicableUnknownNCT04240145
What this trial is testing

Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Gehad Abd Elaziz Mhmoud Ahmad 35
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Post-approval studies (Phase 4)Study completedNCT04977661
What this trial is testing

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Kafrelsheikh University 102
Testing effectiveness (Phase 2)Study completedNCT04210245
What this trial is testing

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 160
Not applicableStudy completedNCT03490370
What this trial is testing

Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisInsulin Sensitivity
NHS Tayside 8
Testing effectiveness (Phase 2)Study completedNCT03812029
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Steatohepatitis
Enyo Pharma 120
Not applicableLooking for participantsNCT06707129
What this trial is testing

Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal

Who this might be right for
Non-alcoholic Fatty Liver Disease
Beijing Municipal Administration of Hospitals 50
Large-scale testing (Phase 3)UnknownNCT04193982
What this trial is testing

An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NAFLD
Asian Institute of Gastroenterology, India 250
Very early researchStudy completedNCT02726542
What this trial is testing

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

Who this might be right for
NAFLD
Massachusetts General Hospital 24
Very early researchWithdrawnNCT01807910
What this trial is testing

ER Stress in NAFLD

Who this might be right for
ObesityNAFLD
Vanderbilt University
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Testing effectiveness (Phase 2)Ended earlyNCT04175392
What this trial is testing

Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

Who this might be right for
Fatty Liver DiseaseFibrosis, LiverCirrhosis, Liver+1 more
Corewell Health East 14
Testing effectiveness (Phase 2)UnknownNCT00699036
What this trial is testing

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease
Brooke Army Medical Center 165
Not applicableStudy completedNCT03774511
What this trial is testing

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Who this might be right for
DiabetesNonalcoholic Fatty Liver DiseaseObesity+1 more
Ahlia University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583344
What this trial is testing

Phase 2b Study of GSK4532990 in Adults With NASH

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 284
Not applicableStudy completedNCT01100398
What this trial is testing

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy

Who this might be right for
Fatty Liver
Brooke Army Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Next Page